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Infection with certain organisms is often found to produce a  high degree of 
resistance  towards  other,  unrelated  organisms  (1).  The  phenomenon  is  con- 
spicuous whenever the immunising infection is caused by a  facultafive intra- 
cellular  parasite  (2).  The  latter  provokes  an  immune  response  with  three 
peculiarities:  a  consistent  association  with  delayed-type  hypersensitivity,  a 
form of acquired  resistance  that  cannot be passively transferred  with serum, 
and a  reported change in the antibacterial  activity of the host's macrophages. 
It is usual  to  dismiss  the  cross-resistance  caused  by such  organisms  as  an 
example of "non-specific immunity," and to ignore the possible immunological 
significance  of the phenomenon.  It was decided  to reinvestigate  the problem 
in the hope of arriving at a better understanding of the immunological processes 
involved in  this  type  of acquired  antibacterial  resistance.  In this  report  the 
specificity of both the induction and the expression of acquired resistance  has 
been studied in mice immunised with three facultative intracellular  parasites; 
Listeria monocytogenes,  Brucella abortus,  and Mycobacterium tuberculosis. 
Materials and Methods 
Mice.--The mice used were of an outbred strain  (3). Animals of the one sex and of compar- 
able age (7 to 8 weeks) were used in individual experiments. 
Organisms.PThe strain of L. monocytogenes (NCTC 7973, serotype I) was sustained at high 
virulence by continuous passage in normal mice. The attenuated vaccine strain of Br. abort,  us 
(strain 19) was obtained from the Commonwealth Serum Laboratories (Victoria). Both organ- 
isms were grown in brain-heart  infusion broth (BI-II, Difco Laboratories, Inc., Detroit).  Sus- 
pensions of bacteria were prepared from 16-hour and 3-day cultures of L. monocytogenes and 
Br. abortus, respectively. The organisms were washed once and resuspended in Hanks' solution 
containing 0.1 per cent bovine serum albumin (fraction V, Armour). The LDs0 for L. monocy- 
/ogenes was 1.0 X  105 by intravenous injection; that for Br. abor/us (strain 19) was not deter- 
mined. 
Bacterial Enumeration in the Spleen.--The  method  of determining  the  viable  bacterial 
count in the spleen was previously described (3). Colony counts were made after 24 hours and 
4 days for/./stcr/a and Brucdla cultures respectively. 
Dete~$ion of Listcria-Resistant Macrophages.--The method used for preparing and parasifis- 
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ing monolayers of mouse macrophages, and for washing them free of extracellular bacteria has 
already been described (3). The method for assessing the antibacterial activity of the cells, 
however, was modified in order to sample a larger proportion of the cells in a given population 
than was possible with the earlier plaquing techinque. Duplicate monolayers in open well-slides 
were maintained in culture for 24 hours at 37°C.  They were washed twice before infecting 
them with a bacterial suspension containing 5 X  106 Zisteria/ml of a culture medium consist- 
ing of 20 per cent foetal calf serum in Hanks' balanced salt solution. After 1 hour at 37°C the 
cultures were washed over a fountain with 200 ml of sterile saline, and one of them was fixed 
and stained to determine by direct microscopic count the number of bacteria present in the 
monolayers (3). The other was incubated for a further 5 hours in bacteria-free medium. This 
was then removed and the monolayer was left momentarily to dry before overlaying it with 
nutrient agar at  45"C. After a  further  18  hours' incubation the cultures were  illuminated 
with a  darkfield condenser, and the numbers of bacterial microcolonies that had arisen were 
counted in a sample area, or over the entire culture if not too numerous. 
Soluble Brucdla Antigens.--A  4-day culture of Br. abortus (strain 19) grown in BHI medium 
was centrifuged to remove bacteria and sterilised by membrane filtration. The culture filtrate 
was used to test for hypersensitivity without further treatment. 
Test for Drayed-Type Hypersensitivity.--Filtrate was injected in a volume of 50 #1 into the 
right hindfoot-pad. The injection site was inspected after 6 to 8 hours to exclude an immediate 
reaction, and after 24 hours the thickness of each hindfoot was measured to 0.05 mm with dial- 
gauge calipers. The response was expressed as the percentage increase in thickness of the in- 
jected over the unlnjected foot. 
RESULTS 
The Bacterial Growth Pattern and Host Response of Mice Infected with Br. 
abortus (Strain  19).--It was first necessary to determine the growth curve of 
Br. abortus in the mouse spleen and to deduce from this the time course of the 
host's response to the infection. In addition, the onset and the level of delayed- 
type hypersensitivity developed towards Brucella antigens was measured by 
foot-pad tests performed at intervals during the infection. 
Mice were infected with Br. abor~us by intravenous injection of approximately 5 X  106 or- 
ganisms. Twenty-four hours later and then at 4-day intervals, 5 mice were used to determine 
the content of viable organisms in whole spleen homogeuates. At 2-day intervals foot-pad 
tests were performed on 5 mice injected with 0.05 ml of a sterile culture filtrate of Br. abortus. 
The residual thickening at 24 hours in 5 normal (uninfected) mice injected with the same dose 
of culture filtrate was subtracted from the mean increase in foot-pad thickness found in the 
mice of the infected group. In no case did the residual foot-pad thickening of control mice ex- 
ceed 5.5 per cent (range 3.7 to 5.5). Mice were used only once in tests for hypersensitivity. 
Fig. 1 shows the growth pattern of Br. abortus in the spleens of normal mice, 
and the corresponding level of hypersensitivity found at each stage of the in- 
fection. The spleen  counts indicate that the organism multiplied slowly for 
the first 9 days. Multiplication then ceased and the Brucella population under- 
went partial inactivation. This phase was followed by a  period of latency in 
which the spleen count remained relatively constant. The spleen counts showed 
surprisingly little variation among mice at any stage.  Much more variation 
was found in a Listeria infection (3). G.  B.  ~cr, a~ss  107 
A  typical  delayed-type  hypersensitivity  developed.  It  was first evident on 
the 5th day and increased rapidly for several days. Sensitivity then diminished 
to relatively low levels as the bacterial population approached its peak. During 
the period of bacterial inactivation it rose again and remained high throughout 
the period of observation. 
The Growth of L. monocytogenes in the Spleens of Mice Infected with Br. abortus 
(Strain 19).--It  appeared from the foregoing results that an infection of mice 
with this strain of Br. abortus is divisible into three distinct phases. It was de- 
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FIG. 1.  Mean viable count and standard deviation in the spleen (O  O), and the corre- 
sponding level of deiayed-type hypersensitivity to Brucdla antigens (O  O) found at inter- 
vals during a primary Br. abortus infection in normal mice. Five mice per group. 
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cided to test for resistance to L. monocytogenes at each phase, and at the same 
time to examine the peritoneal macrophages  of the Brucella-infected animals 
for  their  ability  to  inactivate  L.  monocytogenes in  vitro. A  smaller  dose  of 
Brucella was used in the hope that each phase of infection would be more pro- 
tracted. 
A large group of mice was injected intravenously with a dose of 5.6 X  105 viable Br. abortus. 
Some of the animals were used for establishing the Brucella  curve in the spleen, and the re- 
mainder, together with an equal number of uninfected control mice, were divided into groups 
of 36. On the, 4th 18th, and 35th days of the Bruadla infection the mice of one group, and 
their controls,  were challenged intravenously with L.  monocytogenes (approximate  dose,  0.5 
LDs0).  Following  each  challenge  the growth  curve  of  Listeria was determined  from  viable 108  ACQUIRED  CELLULAR  RESISTANCE 
counts made on the spleens of 6 normal and 6 Bruce/~a-infected animals killed on successive 
days. Monolayer cultures were prepared from the peritoneal washings taken from mice killed 
12 hours after the Li~teria challenge. These were tested for anti-Listeria activity in the manner 
described under Materials and Methods. 
It can be seen from the upper part of Fig. 2 that the growth of Br. abortus 
in the spleen followed a pattern similar to that of the previous experiment in 
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Fro. 2.  Top: Growth curve of Br. abort,  us in the spleens of normal mice. Means of 5 mice per 
group. Bottom: Growth curves of a challenge inoculum of L. monocytogcnes, injected at stages 
(arrowed) during the course of Brucella infection shown above. •  •,  normal controls; 
0---•,  Bruce//a-infected mice. Means of 6 mice per group. 
The content of Lis/~ia-resistant macrophages in the peritoneal cavity at the time of chal- 
lenge is shown below the figure (see aho Table I). 
which these phases were described. The three inocula of L. monocytogenes that 
were injected on days 4, 18, and 35 behaved in a manner that was characteristic 
of the phase of the BruceUa infection at that time. This is depicted in the lower 
half of Fig. 2. When injected on the 4th day the Listeria went through a normal 
growth cycle in  the  spleen.  Those injected on the  18th day, however, were 
rapidly inactivated. Indeed the rate of inactivation exceeded that seen at the 
height of an immune response to L. monocflogenes itself (3). By the 35th day, o. 13. ~cr~mss  109 
the Listeria were again able to multiply in the Brucella-infected  spleen, but 
the rate of growth was somewhat reduced. 
The marked differences in the behaviour of L. monocytogenes in the spleen 
at successive stages  of the Brucdla infection were faithfully reflected in the 
macrophage populations  recovered from the  peritoneal cavity at  the  corre- 
sponding times. This is shown in the data of Table 1 which sets out the numbers 
of microcolonies which arose in monolayers of Listeria-infected  macrophages 
obtained from the normal or Brucella-infected  mice. It will be seen that more 
than 99.9 per cent of the bacteria present in the cultures from the Brucdla- 
infected animals  on the  18th day had been inactivated.  Direct counts con- 
sistently showed, moreover, that the cultures of immune cells prepared at this 
TABLE I 
Numbers of Microcolonies Arising in Monolayers of Listeria-Infected  Macrophages 
Obtained frora Normal or Brucella-Infecled Mice 
Br~ella infection 
Mouse  Day 4  Day 18  Day 35 
Brucella- 
Normal  infected 
0.8  X  10" 
1.1X  10" 
0.9 X  10" 
1.9  X  10" 
1.2  X  10" 
1.0 X  10" 
Br~ella- 
Normal  infected 
1.9  X  10  4  2.1  X  10" 
1.1  X  10"  1.6  X  10" 
2.8  X  10"  1.9  X  10" 
1.0  X  10"  0.8  X  10" 
0.8  X  10"  0.9  X  10" 
3.6  X  10"  2.5  X  10" 
1.9  X  10"  1.6  X  10" 
Bru¢ella- 
Normal  infected 
0.9  X  i0  ~  7 
1.9  X  10.  17 
2.8  X  10.  40 
1.1  X  10"  24 
1.9  X  10"  15 
2.6  X  10"  10 
1.9  X  10"  17 
1.2  X  10. 
1.3  X  10. 
1.6  X  10' 
2.9  X  10. 
118 X  10' 
1.6 X  10. 
Mean...  1.2  X  10'  1.2  X  10" 
time contained more intracellular Listeria  than were present in  the  control 
cultures. This capacity of the macrophages to inactivate Listeria  in vitro had 
diminished considerably in the monolayers prepared from the BruceUa-infected 
mice on the 35th day of infection. 
Tke Growth of Br. abortus (Strain 19) in the Spleens  of Listeria-Immunised 
Mice.--It was not possible to reverse the plan of the previous experiment for 
the purpose of studying the behaviour of Br. abortus in the spleens of Listeria- 
immune mice. Not only are the time relations quite different, but there is also 
the difficulty that immunisation with L. monocytogenes necessitates the use of 
living organisms. This meant that mice could not be challenged with Br. abortus 
earlier  than  the  7th  day of  the  immunising  Listeria  infection, because  the 
Listeria,  being more numerous and faster growing than Brucdla, would have 
obscured the plates. 110  ACQUIRED  CELLULAR  RESISTANCE 
Mice were injected intravenously with a sublethal dose of L. raonocytogvne,  s  (0.1 LD60). 
Seven days later they were challenged, together with a group of unlmmunised controls, by the 
intravenous injection of living Br. abort~us. At intervals the spleens of 6 mice were homogenised 
for enumeration of their content of viable Brucdla. 
Fig. 3 shows the growth curves of Br. abortus in the spleens of normal mice 
and of mice infected with L. monocytogenes 1 week previously. The numbers of 
viable  Brucella  present  in  the  spleens  of  the  Listeria-immunised  mice  were 
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FIo. 3.  Growth curves of Br. abort~u,~  in the spleens  of normal mice (O  Q) and mice  in- 
fected 7 days previously with a sublethal dose of L. monocytogo~es (0  0). Means of 6 mice 
per group. 
fewer at 24 hours than in controls, and showed little evidence of increase during 
the next 5 days. Beyond the 1st week they grew at an equal rate in normal and 
immunised animals. Apparently the antecedent Listeria infection had created 
in  the  spleen  a  short-lived change  affecting the  growth  and  survival of Br. 
abortus.  The finding that this effect did not persist longer than 2 weeks from 
the initiation of the Listeria infection is consistent with a previous observation 
that the period of absolute resistance to reinfection of the spleen with Listeria 
itself is of similar duration.  It corresponds to the time during which the peri- 
toneal macrophages were found  to be resistant  to Listeri,  a  in vitro  (3).  Later 
in the convalescence of Listeria-infected  mice the  reinjection of L.  monocyto- G.  ]3.  ~CKA~WSS  111 
genes produces a rapid reactivation of the immune mechanism.  This being so, 
it seemed possible that a sustained level of resistance to Br. abartus in Listeria- 
immunised animals  could be produced by periodic  reinfection  with L. morw- 
cytogenes. 
Mice were infected intravenously with approximately l0  s Br. abar$us. Twenty-four hours 
later half of them were injected intravenously with a small (0.01 LDs0)  immunising dose of 
L. m~n~ocyDgenez. Those remaining unused on the 5th and 9th days were given a larger (10 
LD~0) reinfecting dose of L. monocytoge~es by the same route. The growth of Br. abarlus in 
the spleens of the untreated and Listeria-immunised mice was determined in the usual way. 
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Fro.  4. Growth and survival  curves  of  Br. abort~ in the spleens  of  normal mice (O  O) 
and of mice infected  on day 1 (0.01  LDs0), and rdnfected on days 5 and 9 (10.0  LDs0) with 
living  L. monocytog~es (O--O).  Means of five  mice per group. 
Fig. 4 compares the growth pattern of Br. abortu~ in the spleens of untreated 
mice and of mice repeatedly reinfected with L. monocytogenes during the course 
of a primary Brucella infection. It is apparent that the L/ster/a infection caused 
a very effective and persisting  inhibition of the growth of Br. abortus. The re- 
sistance to BrnceUa appears  to have been due entirely to the effects produced 
by the Listeria infection, for it had commenced by the 4th day (3), and was well 
established  long before  the untreated mice showed evidence  of the onset of 
resistance  induced by Brucella itself. 
The Specificity of the Recall of Acquired Resistance to L. monocytogenes and 112  ACQUIRED  CELLULAR  RESISTANCE 
Br. abortu3.--It will be noted from Fig. 3 that the inhibition of Br. abortus was 
short-lived  in animals immunised with a single dose of L. monocytogenes. Be- 
yond the 5th day the challenge organism grew as rapidly in immunised animals 
as it did in normal controls. This seemed to indicate that the recall of acquired 
resistance  involves a mechanism  that is immunologically specific. This ques- 
tion was examined in both Listeria- and Brucella-sensitised animals. 
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FIG, 5.  Growth and survival curves of Bt. abortus (left) and L. monocytogenes (right) in the 
spleens of normal mice (0  O) and mice immunised 4 weeks previously with a sublethal 
dose of L. raonocylogenes (O  O). Means of 6 mice per group. 
Listeria-Sensitised  Mice.-- 
Mice were injected intravenously with a primary immunising dose of L. monocytogenes (0.1 
LDso).  Four weeks later half of them were challenged  intravenously with virulent Listerla 
(1.0 LD60),  and the other half with Br. abort,  us (1.6 X  10s). Two other groups of control mice 
were challenged in the same way at the same time. Viable counts were performed at intervals 
on the spleens of 6 mice from each group. 
Fig. 5 shows a comparison between the growth of Br. abortus and L. mono- 
cytogenes in the spleens of normal mice and mice which had been immunised 4 
weeks  previously with  L.  monocflogenes.  Whereas  the  challenging  dose  of 
Listeria  evoked  an  accelerated  immune response  in  the  tissues  of Listeria- 
sensitised mice, Br. abortus failed to do so. Reference to Fig. 2 will show that 
L.  monocytogenes injected during the latent phase  (day 35)  of a  Brucella in- o.  B.  MAC~n.~SS  113 
fection grew slowly but without interruption  for at least 4  days, indicating 
again that  heterologous organisms  are incapable of reactivating  the antibac- 
terial mechanism of sensitised mice. 
Brucella-Sensitised Mice.--Use was made of the fact that mice infected with 
Br. abortus (strain 19) pass into a latent phase in which viable organisms  per- 
sist in the tissues in relatively small numbers (Fig. 2). In view of the foregoing 
results it would be expected that reinfection of such animals  with homologous 
organisms would reactivate the host's bactericidal mechanism and disturb the 
established balance between the host and the original parasite population. 
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FIo. 6.  Bacterial inactivation curves in the spleen during the 3 to 5 week interval following 
a primary Brucdla infection in normal mice (O ""  0) and in mice reinfected on days 21 and 
27  (arrowed)  by the intrapetitoneal injection of 10  s living Br. aborh~s (O  O), or BCG 
(A  -A). Means of 5 mice per group. 
Mice were infected intravenously with about 106 Be. ahortus  (strain 19). Spleen counts on 
groups of 5 mice were made at intervals beginning on day 13 of the infection. On days 21 and 
27 some of the mice were injected intraperitoneally with BCG or Br. abor~us in a dose of 10  s 
organisms. The remainder was left untreated.  The numbers of viable Bruce.IJa found in the 
spleens of the reinfected and unchallenged mice are shown in Fig. 6. 
The peritoneal route of reinfection was chosen in order to mlnimise the num- 
ber of new organisms entering  the spleen.  It was hoped that  in this way it 114  ACQUIRED  CELLULAR RESISTANCE 
would be possible to study the fate of the original spleen population of Brucella. 
Despite the certainty that a number of organisms from the reinfecting inoculum 
entered the spleen, the viable Brucella count fell in the spleens of mice reinfected 
with Br.  abortus.  It did not change in mice challenged with BCG, indicating 
again the specificity involved in the process of activation of the antibacterial 
mechanism. 
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Fta. 7.  growth curves of L. monocytogenes in the spleens of normal or BCG-sensitised mice 
given an intravenous injection of BCG 3 days prior to challenge with L. monocytogcnes. 
O~O,  normal mice;  ©  O, BCG-sensitised  mice; ×  X, normal mice given BCG 
prior to challenge; A  A, BCG-sensitised mice given BCG prior to challenge. Means of 6 
mice per group. 
The Effect of Antigen on the Levd of Acquired Cellular  Resistance.--It could 
be argued from the evidence of Figs. 1 and 2 that the only  period during which an 
effective bactericidal mechanism was present in the spleens and the peritoneal 
macrophages  of  Brucella-infected  mice  occurred  in  the  period  immediately 
following the peak concentration of antigenic material in the tissues. A com- 
parison of Figs. 3 and 4 also indicates that persistence of antigen in the tissues 
of Listeria-immunised  animals is  a  necessary condition for the expression of 
resistance against Br. abortus.  This raises the interesting question of whether 
the bacterial antigens are themselves playing a critical role in the induction of 6.  B.  ~CKAZTESS  115 
acquired cellular resistance. In order to investigate this point, and to add fur- 
ther evidence on the question of specificity, a study was made of the effect of a 
sudden increment in the antigen content of the tissues of BCG-sensitised mice. 
Mice were injected intravenously with 0.25 mg (moist weight) of a vaccine  strain of BCG. 
Half of the sensitised animals, and an equal number of normal mice, were given a second in- 
travenous injection of BCG 14 weeks later when their spleens still contained viable tubercle 
bacilli. An mice, together with an additiOnal group of untreated controls were challenged in- 
travenously with L. mtmoeytogotea (1.0 LDr0) 3 days following  the second injection of BCG. 
The numbers of viable Listeria in the spleens of 5 mice from each of the four groups were de- 
termined at daily intervals. 
Fig. 7 shows the growth curves of L. monocytogenes in the spleens of mice of 
the four treatment groups of the foregoing experiment. The curves show three 
significant features. (a) The rate of growth of Listeria was diminished in BCG- 
immunised mice and was comparable with that seen in the latent phase of a 
Brucella infection (Fig. 2). (b) There was no evidence of an accelerated immune 
response to Listeria in BCG-sensitised animals. (c) A marked effect on survival 
and growth of Listeria occurred when BCG was injected into BCG-sensitised 
animals, but not when injected into normal mice. 
DISCUSSION  I  (,t 
The antibacterial mechanism which develops in mice infected with L. mow- 
cytogenes,  Br.  abortus,  or  M.  tuberculosis  is  clearly not  directed exclusively 
against the organism which provoked it. It is, in fact, quite non-specific. The 
extreme  antigenic  diversity  among  the  bacterial  species  which  promote  a 
mutual  cross-resistance makes  it  unlikely that  the  mediator is  an  antibody 
which modifies the bacterial cell by direct union with it, as in opsouisation or 
bacteriolysis. The experiments in the  preceding paper (4)  support this view. 
They failed to show evidence of any free or cell-bound antibody in Listeria- 
immune  mice  that  could significantly influence the  survival  and  growth  of 
L. monocytogenes in a wide variety of test systems. 
On the other hand previous studies (3-5), and some of the present observa- 
tions, have shown that the macrophages of immunised animals acquire anti- 
bacterial properties that  are not found in the cells of normal animals.  Since 
acquired resistance may sometimes be due entirely to this change in cellular 
activity, it is important to enquire into the mechanism of its induction. 
The present  studies have shown that  the underlying events which lead to 
altered  functional  activity in  host  macrophages  are  immunologically deter- 
mined and specific in nature. The evidence depends upon the finding that re- 
infection with homologous organisms effectively recalls the state of acquired 
resistance,  while  challenge  with  heterologous organisms  does not.  This  was 
true of all cases that could be tested conveniently. It can be concluded, there- 
fore,  that  infection produces  a  state  of  immunological  reactivity which  is 
susceptible to activation only by the microbial antigens to which the host has 116  ACQUIRED CELLULAR RESISTANCE 
been rendered sensitive. For the reasons already given it is unlikely that this 
state of reactivity is merely a  capacity to respond anamnestically by an ac- 
celerated production of antibody; for this would not explain the absence of 
specificity in the ultimate mechanism of bacterial inactivation. For instance, 
the reinjection of BCG into BCG-sensitised animals produced a marked degree 
of  resistance  to  L.  monocytogenes; the  reinjection of  L.  monocytogenes into 
Listeria-sensitised  animals produced a sustained resistance to Br. abortus, and 
the injection of Br. a~ortus into Brucetla-sensitised mice produced macrophages 
with anti-Listeria  activity. It seems, therefore, that non-specific resistance re- 
appears, or is augmented, soon after the introduction of the specific microbial 
antigens to which the tissues are already sensitive. If this is true, it implies 
that both antigen and specific sensitisation of the tissues are necessary factors 
for the induction of this form of acquired resistance. 
The nature of the background of sensitisation which appears to be essential 
for the induction of acquired cellular resistance has not yet been identified 
with certainty. It must be considered highly significant, however, that all the 
organisms used in the present study provoke an immune response attended by 
delayed-type hypersensitivity. In view of the absolute specificity of the recall 
of acquired resistance and the known specificity of delayed hypersensitivity 
to Brucella,  Listeria,  and mycobacterial antigens, it is worth discussing the 
possibility that both these immunological phenomena are mediated by the same 
antibody. 
Delayed-type hypersensitivity to the respective soluble antigens of L. mono- 
cytogene.s (3) or Br. abortus (Fig. 1) occurred in each case on about the 4th day 
of a primary infection. In the former the onset of the antibacterial mechanism 
also occurred on the 4th day, but in brucellosis it was delayed for a further 5 
or 6 days. Br. abortus is a much more slowly growing organism, and is more 
resistant to inactivation (Fig. 2).  If release of antigen into a  hypersensitive 
host is an essential step in the induction of acquired resistance, it would be ex- 
pected that the antibacterial mechanism would emerge more slowly in a Br~dla 
than in a Listeria  infection. 
In the present context it is significant that the level of hypersensitivity to 
Bruc,  dla antigens fell as the Brucella population approached its peak (Fig. 1). 
This can be taken as an indication that antigen was being released in amounts 
sufficient to cause partial desensitisation of the host. It was during this period 
that the antibacterial mechanism was most efficient. The coincident onset of 
hypersensitivity and resistance in a Listeria  infection and the desensitisation 
that occurred at the time of active bacterial destruction in a Brucdla infection 
both point to a significant relationship between hypersensitivity and acquired 
cellular resistance. It is clear, however, that the antibacterial mechanism is not 
due to hypersensitivity alone, for hypersensitivity was present in higher degree 
both early and late in the infection when resistance was absent or low. But G.  B.  ~ACXA~mSS  117 
at these times the bacterial population was small, and the extent of the allergic 
reaction occurring in the tissues would be correspondingly reduced. If this ex- 
planation is correct, it follows that the introduction of additional antigen during 
a latent infection, or during convalescence in the case of listeriosis,  should be 
accompanied by a  prompt increase in the level of host resistance. This was 
shown to occur in each of the three infections used in the present investigation 
(Figs. 4, 6, and 7). 
Some of the features of a tuberculous infection are consistent with the fore- 
going hypothesis that acquired cellular resistance depends upon antigenic ac- 
tivation  of  tissues  sensitised  to  specific  microbial  antigens.  The  protective 
effects of vaccination with BCG can be revealed in a  number of ways: by a 
difference in survival time of the host, a reduction in the number of virulent 
organisms in the tissues at an interval following challenge, or by a difference in 
the  severity of lesions.  However,  when  quantitative  studies  were  made by 
L6vy et al. (6), it was found that similar numbers of viable organisms could be 
recovered from normal and vaccinated animals for some time following chal- 
lenge, and that equivalent numbers of microscopic lesions developed in relation 
to them. Evidently the benefits of vaccination were not immediately available 
to the host, but were invoked by the challenge organism itself. In terms of the 
present hypothesis, the delay in the onset of resistance is explained by the time 
needed for the virulent organism to increase in numbers to a point at which the 
amount of antigen being released into the tissues is sufficient to activate the 
antibacterial mechanism of host macrophages. 
At present we know very little of the nature of the antibody that confers 
delayed-type hypersensitivity, the highly specific nature of which demands the 
existence  of patterned  molecules that  are  capable  of  reacting with  the  de- 
terminant groups of the corresponding antigens. Boyden's recent studies (7) 
have  suggested  that  delayed-type hypersensitivity may be  mediated  by  a 
cytophilic antibody which possesses  a strong aff~ity for the surface of macro- 
phages. If the antigen-antibody reaction which is postulated to form the basis 
of acquired cellular resistance be true, no better location for the hypothetical 
antibody could be imagined than on the surface of the macrophage itself. The 
interaction of antigen and antibody would then take place on the very cells 
which are now known to undergo changes during infection. Apart from their 
striking antibacterial properties, the macrophages of immunised animals show 
gross differences in morphology (3) and minor differences in ultrastructure (8). 
They show metabolic activity in excess of that found in normal cells (9)  and 
cytochemical evidence of altered metabolic habit (10). The likelihood that some 
of these changes are due to a stimulating effect of antigens on sensitised cells is 
evident from the studies of Waksman and Matoltsy (11),  and from the fact 
that  the  macrophages  of  animals  allergically sensitised  to  soluble  antigens 
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jected (12).  Evidence will be presented in a forthcoming publication that the 
sensitised host responds to bacterial antigens in exactly the same way (13). 
The fact that the macrophages of sensitised animals respond to specific antigen 
by DNA synthesis and subsequent division is of potential significance in rela- 
tion to the mechanism of acquired cellular resistance. This is true whether the 
response of macrophages is due to a direct effect of antigen on cells sensitised 
by adsorbed antibody, or whether it is due to a more complex train of events. 
The proposition that the mediator of delayed-type hypersensitivity provides 
the immunological reactivity upon which acquired cellular resistance depends 
will be criticised by those who believe that hypersensitivity and acquired re- 
sistance are separable phenomena (14, 15). Evidence for the latter view usually 
takes one of two forms: the finding that resistance tends to persist in animals 
which have  been desensitised by the  repeated  injection of antigen  (16);  or 
that appropriate bacterial extracts can cause increased resistance without pro- 
ducing cutaneous sensitivity (17)  or cutaneous sensitivity without increased 
resistance (18). None of this evidence is in conflict with the view that resistance 
depends for its full expression upon the presence of hypersensitivity. Although 
the injection of antigen may eliminate cutaneous sensitivity (a small single in- 
jection of culture filtrate will completely desensitise Listeria-sensitised mice for 
several days, reference  19),  it  does  not  necessarily eliminate  the  activated 
macrophages upon which resistance depends. Indeed, according to the present 
evidence it would tend to promote them to increased functional activity. The 
production of resistance without hypersensitivity may merely mean that the 
immunising antigen has produced a primary antibody response of very small 
proportions, but sufficient to ensure a  rapid anamnestic response on challenge 
and the consequent background of hypersensitivity upon which resistance de- 
pends. The production of sensitivity in the absence of increased resistance, for 
instance by the injection of PPD and bacillary wax (18), is more difficult to ex- 
plain. We should remember, however, that such procedures invariably produce 
a precipitating or Arthus-type of antibody in addition to the antibody which 
mediates delayed-type hypersensitivity (20, 21). It is possible that circulating 
antibody would seriously interfere with the immune mechanism by combining 
with free antigen, and thus reduce its effective concentration so far as the reac- 
tion with sensitised macrophages is concerned. The case of graft enhancement is 
perhaps analogous (22).  It should be remembered, too, that when tuberculosis 
is the subject of study a very long time elapses before the results of challenge 
are known. This leaves time in which all manner of change can occur in the 
level of hypersensitivity and in the concentration of microbial antigens in the 
tissues. As we have seen in the case of a Brucella infection, host resistance and 
cutaneous sensitivity are subject to wide fluctuation. They seem to vary in- 
versely with the prevailing size of the parasite population. There is clearly a 
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The foregoing speculations on the nature of acquired cellular resistance were 
prompted by the important consideration that out of a specific immunological 
reaction, a non-specific antibacterial mechanism emerges. It is unlikely, there- 
fore, that bacterial inactivation is the consequence of an antigen-antibody reac- 
tion taking place on the bacterial cell, for this would not explain the host's be- 
haviour towards heterologous organisms. It seems more likely that the reaction 
takes place between antigen and a host component which has become sensitised 
by the adsorption of specific antibody. The macrophage surface seems to provide 
an ideal site for this proposed antigen-antibody reaction to occur. This interpre- 
tation of acquired cellular resistance has certain merits, for it explains why re- 
sistance tends to be short-lived in those infections in which the antibacterial 
mechanism depends for its full expression upon the continuing presence of anti- 
gen, as in the well known instances of infection immunity. It also explains the 
non-specific nature of this type of acquired resistance, because it involves modi- 
fication of the host rather than the parasite, and it leads to a better understand- 
Lug of why an infection tends to become latent as the antigenic stimulus from a 
diminishing microbial population gradually subsides. 
SUMMARY 
The  resistance  developed  by  mice  during  infection  with  List~ria  ~zono- 
cytogenes,  Brucella  abortus,  or Mycobactcrium  tuberculosis  is  not  specifically 
directed against the infecting organism. The processes involved in the induction 
of acquired resistance, however, are highly specific and seem to depend upon 
two factors: a state of immunological reactivity of the host and the presence of 
the specific microbial antigens to which the host has become reactive. When 
these two coexist in the tissues the host is found to be non-specifically resistant. 
It is suggested that resistance, which was shown to depend upon an altered state 
of host macrophages, may be due to the interaction of antigen and a specific 
antibody adsorbed to the surface of host macrophages; and that the antibody 
involved in the reaction is perhaps identical with the antibody which confers the 
state of delayed-type hypersensitivity. The results are discussed  in relation to 
the question of latent infection and infection immunity. 
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